Gujarat State Fertilizers & Chemicals Limited (GSFC) makes its money from two distinct businesses: a subsidised fertiliser franchise (urea, DAP, NPK, APS) that contributes roughly 65% of revenue and a smaller industrial chemicals portfolio (caprolactam, melamine, HX Crystal, sulphuric acid) that is the real profit engine when spreads cooperate. In Q1 FY27 the fertiliser segment delivered record sales of INR 2,947 crore, up 65% year on year, while the industrial segment earned INR 116 crore of EBIT on INR 635 crore of sales, its second best ever. The competitive structure is split: DAP and urea are fully subsidy-covered with a fixed 4% margin over import cost, making them regulated but predictable, while NPK and APS are effectively price-controlled by farmer affordability, leaving GSFC exposed to input cost swings. The industrial niche is narrower; GSFC is the only Indian producer of melamine, caprolactam and HX Crystal, but Chinese imports have forced melamine production to zero. Overall operating margins are thin, 4-6% for the fertiliser segment, but the balance sheet carries no long-term debt, and the company has been reinvesting for years.
The economics persist mainly through government protection and captive raw materials, not through pricing power. DAP margins are guaranteed by the special package, and the urea revamp completed in June 2025 locks in subsidy at old energy norms for three years, giving a payback of INR 350-400 crore over 4-5 years. Captive sulphuric acid production covers roughly all of the Baroda requirement and part of Sikka, insulating the company from the 91-130% spike in sulphuric acid and sulphur prices seen in Q3 FY26. The industrial segment's edge is the caprolactam-benzene spread, which recovered to over $800 per tonne in Q1 FY27 versus $495 in Q3 FY26, and the sole-producer status for HX Crystal and melamine, though the latter is currently unviable without anti-dumping duty or price support. These are not classic moats; they are policy-dependent and susceptible to global chemical cycles, so the persistence of high margins requires continued government backing and cost discipline.
The inflection is already underway. The Sulphuric Acid-V plant was commissioned on 7 January 2026, adding 2 lakh tonnes per annum of capacity and generating an estimated INR 100 crore of annual savings from lower purchases and steam recovery. The DAP train at Sikka is being converted to produce fungible APS or DAP, with the latest August 2026 call confirming completion within one to two months, meaning by around October 2026. Beyond that, the board approved new integrated fertiliser and industrial chemical projects at Dahed on 12 August 2026, with details to be disclosed by November 2026, and a phosphoric/sulphuric acid project at Sikka is in tender evaluation. Eighteen to twenty-four months from now, by mid-2028, GSFC should have flexible DAP/APS production, captive acid for both sites, a fully revamped urea plant still earning old-energy subsidy, and a new integrated complex at Dahed that will lower raw material costs across the portfolio. Fertiliser volume is budgeted at over 22 lakh metric tonnes for FY27, and management expects to exceed that, with Q1 already at 5.26 lakh tonnes up 17% year on year. If the new projects come online as planned, the cost base will be materially lower, and industrial margins should benefit from sustained caprolactam spreads and higher HX Crystal exports from EU FTA and US tariff concessions.
Management walk-talk has been mixed. On volume they largely delivered: FY26 fertiliser sales hit 22.31 lakh tonnes, close to the 23-24 lakh guided, and APS/AS volume of 10 lakh tonnes was reiterated and tracked. But the May 2025 guidance of INR 3,000 per tonne fertiliser EBITDA has slipped badly; Q2 FY26 EBIT per tonne was around INR 1,800, and by February 2026 management only said overall fertiliser EBITDA would stay at 5-6%. Capex timelines have also slipped: Sulphuric Acid-V was promised within months in August 2025 but only commissioned in January 2026, and the Sikka DAP conversion was originally slated for September 2025, then pushed to September 2026, and is only now on schedule for October 2026. The positive side is that the BCG operational efficiency programme has already delivered INR 20-25 crore of benefit in Q1 FY27, with more expected, and the company has maintained zero long-term debt while funding inventory with INR 500 crore of short-term borrowings. The latest call shows management still confident in exceeding FY27 volume targets but cautious on near-term margins, so credibility rests on whether the promised inflection actually arrives.
The earnings path over the next 18-24 months hinges on three numbers: the INR 100 crore annual savings from the new acid plant, the BCG-driven savings that are already at INR 20-25 crore per quarter and should exceed INR 40 crore annually, and a caprolactam-benzene spread that is now above $800 versus a variable-cost breakeven lower than that. If the DAP/APS fungible train works, GSFC can shift production to whichever product offers better margins, and the government's NBS rate revision due 1 October 2026 is expected to raise subsidy rates to reflect the 30-130% input cost inflation. The single most important falsifier is the October 2026 subsidy revision: if it is insufficient to cover raw material costs, fertiliser margins will stay at 4-5% and the whole operating leverage story collapses. The second watchpoint is the commissioning of the Sikka phosphoric/sulphuric acid project; any delay beyond 2028 would push the integration benefit further out. The tension that needs to resolve is the recent margin compression (operational) versus the capacity additions (structural). If the subsidy revision and raw material normalisation occur, the business will look structurally more efficient with flexible production, captive acid, and no debt; if not, it remains a subsidy-dependent cyclical with thin returns. The current data supports an operating leverage thesis: volumes are growing, costs are being stripped out, and the 2026-2028 capex cycle is the driver.
companyname: Gujarat State Fertilizers & Chemicals Limited ticker: GSFC sector: Fertilizers & Chemicals GSFC is a Gujarat state government promoted fertilizer and chemicals manufacturer, incorporated in 1962 (CIN: L99999GJ1962PLC001121). It operates two manufacturing complexes: Fertilizernagar in Vadodara and Sikka in Jamnagar. The company produces nitrogenous and phosphatic fertilizers (urea, DAP, ammonium sulphate, ammonium phosphate sulphate, NPK complex grades) and industrial chemicals (cap...
Read the full report →capex, margin expansion
No guidance
Guidance no_datamixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Gujarat State Fertilizers & Chemicals Limited and 4,900+ companies.
5-day free pass. No card required.